 4. Patient is not able to swallow oral medication andor has impairment of gastrointestinal GI function or GI disease that may significantly alter the absorption of the study drugs e.g., ulcerative diseases, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome, or small bowel resection. 